{
    "LeadSponsorName": [
        "UCB Pharma",
        "Eurofarma Laboratorios S.A.",
        "Janssen Vaccines & Prevention B.V.",
        "Crist\u00e1lia Produtos Qu\u00edmicos Farmac\u00eauticos Ltda.",
        "bluebird bio",
        "Tolmar Inc.",
        "Abbott",
        "Nektar Therapeutics",
        "Kronos Bio",
        "Novo Nordisk A/S",
        "Genentech, Inc.",
        "ApoPharma",
        "Novartis",
        "Active Biotech AB",
        "Corcept Therapeutics",
        "HUYABIO International, LLC.",
        "Ultragenyx Pharmaceutical Inc",
        "Taiho Oncology, Inc.",
        "Astellas Pharma Global Development, Inc.",
        "Daiichi Sankyo, Inc.",
        "Takeda",
        "Millennium Pharmaceuticals, Inc.",
        "Aragon Pharmaceuticals, Inc.",
        "CanariaBio Inc.",
        "R-Pharm",
        "EMD Serono Research & Development Institute, Inc.",
        "Bioverativ Therapeutics Inc.",
        "Applied Biology, Inc.",
        "Acerta Pharma BV",
        "Kyowa Kirin, Inc.",
        "Shionogi",
        "Ligand Pharmaceuticals",
        "Azidus Brasil",
        "Pierre Fabre Medicament",
        "CancerVax Corporation",
        "Bristol-Myers Squibb",
        "EMD Serono",
        "Janssen Research & Development, LLC",
        "UCB BIOSCIENCES GmbH",
        "Loxo Oncology, Inc.",
        "ViiV Healthcare",
        "Debiopharm International SA",
        "Cellectar Biosciences, Inc.",
        "Brooklyn ImmunoTherapeutics, LLC",
        "Telik",
        "EOM Pharmaceuticals",
        "Nereus Pharmaceuticals, Inc.",
        "Gilead Sciences",
        "R-Pharm International, LLC",
        "Sumitomo Pharma Oncology, Inc.",
        "RayzeBio, Inc.",
        "Merck KGaA, Darmstadt, Germany",
        "Recombio SL",
        "Zodiac Produtos Farmaceuticos S.A.",
        "Genzyme, a Sanofi Company",
        "Abivax S.A.",
        "BeiGene",
        "NovoCure Ltd.",
        "Janssen Sciences Ireland UC",
        "Vical",
        "Eli Lilly and Company",
        "ColubrisMX",
        "Tularik",
        "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.",
        "Inovio Pharmaceuticals",
        "Boehringer Ingelheim",
        "Humanigen, Inc.",
        "Checkpoint Therapeutics, Inc.",
        "Becton, Dickinson and Company",
        "Tesaro, Inc.",
        "Geron Corporation",
        "Alexion",
        "Novartis Pharmaceuticals",
        "RECORDATI GROUP",
        "Janssen-Cilag Ltd.",
        "Janssen Scientific Affairs, LLC",
        "Alaunos Therapeutics",
        "Biozeus Biopharmaceutical S.A.",
        "Seagen Inc.",
        "Guerbet",
        "Heidelberg Pharma AG",
        "Lavilabor Natural Products Ltd",
        "Agenus Inc.",
        "Merck Sharp & Dohme LLC",
        "PharmaMar",
        "Chiltern Pesquisa Clinica Ltda",
        "Crinetics Pharmaceuticals Inc.",
        "medac GmbH",
        "Sanofi",
        "Cryopraxis Criobiologia Ltda.",
        "Polyphor Ltd.",
        "BioNTech SE",
        "pharmaand GmbH",
        "NantCell, Inc.",
        "Basilea Pharmaceutica",
        "Synta Pharmaceuticals Corp.",
        "Kartos Therapeutics, Inc.",
        "Akeso",
        "Janssen-Cilag Farmaceutica Ltda.",
        "Janssen Pharmaceutica N.V., Belgium",
        "Astellas Pharma Inc",
        "Advaxis, Inc.",
        "AVEO Pharmaceuticals, Inc.",
        "Anthera Pharmaceuticals",
        "Teva Branded Pharmaceutical Products R&D, Inc.",
        "F2G Biotech GmbH",
        "Scitech Produtos Medicos Ltda",
        "Jazz Pharmaceuticals",
        "Biogen",
        "PTC Therapeutics",
        "Sandoz",
        "Ipsen",
        "BioMarin Pharmaceutical",
        "Helsinn Healthcare SA",
        "Genmab",
        "Spectrum Pharmaceuticals, Inc",
        "Regeneron Pharmaceuticals",
        "Xcovery Holding Company, LLC",
        "Myovant Sciences GmbH",
        "Baxalta now part of Shire",
        "Halozyme Therapeutics",
        "Mallinckrodt",
        "Biocinese",
        "Asahi Kasei Pharma America Corporation",
        "Incyte Corporation",
        "Intercept Pharmaceuticals",
        "Viracta Therapeutics, Inc.",
        "Sophia Genetics SAS",
        "Wyeth is now a wholly owned subsidiary of Pfizer",
        "Celldex Therapeutics",
        "Libbs Farmac\u00eautica LTDA",
        "Telios Pharma, Inc.",
        "GlaxoSmithKline",
        "Merrimack Pharmaceuticals",
        "Tobira Therapeutics, Inc.",
        "OncoVerity, Inc.",
        "Immix Biopharma, Inc.",
        "Eidos Therapeutics, a BridgeBio company",
        "AstraZeneca",
        "Exelixis",
        "Arcus Biosciences, Inc.",
        "Celgene",
        "Cogent Biosciences, Inc.",
        "Sesen Bio, Inc.",
        "Immune Biosolutions Inc",
        "Mirati Therapeutics Inc.",
        "Threshold Pharmaceuticals",
        "OBI Pharma, Inc",
        "Apellis Pharmaceuticals, Inc.",
        "Janssen Pharmaceutica",
        "Eisai Inc.",
        "Pfizer",
        "Puma Biotechnology, Inc.",
        "Repros Therapeutics Inc.",
        "Hoffmann-La Roche",
        "Otsuka Pharmaceutical Development & Commercialization, Inc.",
        "Uni\u00e3o Qu\u00edmica Farmac\u00eautica Nacional S/A",
        "Boston Scientific Corporation",
        "Human Genome Sciences Inc., a GSK Company",
        "Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
        "OSI Pharmaceuticals",
        "Shire",
        "CSL Behring",
        "Isarna Therapeutics GmbH",
        "SciClone Pharmaceuticals",
        "Recepta Biopharma",
        "mAbxience Research S.L.",
        "ISA Pharmaceuticals",
        "Mylan Inc.",
        "Gamida Cell ltd",
        "Celcuity, Inc.",
        "Morphotek",
        "Amgen",
        "Clovis Oncology, Inc.",
        "Principia Biopharma, a Sanofi Company",
        "Agios Pharmaceuticals, Inc.",
        "AbbVie",
        "Algenis SpA",
        "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
        "Bayer",
        "AbbVie (prior sponsor, Abbott)"
    ]
}